Navigation: =>

Home / Patent catalog / Catalog section / Back /

IMMUNOLOGY. METHODS OF TREATMENT OF THE SYNDROME OF ACQUIRED IMMUNE DEFICIT (AIDS)

INVENTION
Patent of the Russian Federation RU2070059

METHOD OF CLEANING BLOOD FROM VIRUS AIDS

METHOD OF CLEANING BLOOD FROM VIRUS AIDS

The name of the inventor: Lishchishin Emelyan Ivanovich [UA]; Lishchishin Maria Emelyanovna [UA]
The name of the patent holder: Lishchishin Emelyan Ivanovich
Address for correspondence:
Date of commencement of the patent: 1992.04.01

A method of purifying the blood of a living organism from the AIDS virus. The invention relates to medicine and can be used to design devices for artificial blood purification of patients in a clinic from the HIV virus. The aim of the invention is to increase the therapeutic effect of purifying blood from the HIV virus without the use of chemical preparations. The method involves the saturation of blood with ozone in a sealed vacuum chamber with the simultaneous formation of a constant electric field and the subsequent introduction of donor blood to the patient. The method involves the transportation of oxygen to separate human organs without its oxidation, with the blood divided into separate groups: the T-lymphocytes are separated. The blood molecule has the properties of polarization, excitation and conductivity, and the blood forms a certain electric field. The membrane potential of the muscle fiber is related to the difference in the concentration of ions in the muscle fiber and in the extracellular environment. Vacuuming, mixing of blood with ozone and the formation of an electric field is carried out simultaneously. The method is controlled by a microprocessor of mass production.

DESCRIPTION OF THE INVENTION

The invention relates to medicine and can be used to purify blood from the AIDS (HIV) virus of acquired immunodeficiency syndrome of a viral disease affecting the human immune system.

A technical solution is known for purifying blood from the AIDS virus by screening blood through the patient's vein and feeding it into a hermetic chamber, followed by puffing the blood with heated gas, using ozone as the gas (see EI Litsishin "Vacuum kills HIV,". Doctor, No. 5, 1991, p. 26-27).

The disadvantage of the known method is that the incubation period of the AIDS-HIV virus lasts for a certain time and after the virus is cleared, the patient re-emerges the disease (see Inventor and rationalizer No. 5, 1990, page 41, Moscow).

It is known a method and devices for its implementation in physiotherapeutic irradiation of blood with the supply of oxygen and the action of a source of a constant and alternating magnetic field (see author N 1616685, A 61 N 5/06, 1990).

The aim of the invention is to increase the therapeutic effect by restoring blood after it is withdrawn through the patient's vein, irradiation with a magnetic field.

The goal is achieved by the fact that the method is carried out in a sealed chamber by feeding the patient's AIDS to the chamber through a vein, irradiating the blood with a magnetic field, blowing with warmed-up ozone gas, while the magnetic field and ozone blowing are performed simultaneously, a negative electric field is additionally introduced and Donor shelter.

THE METHOD IS PROVIDED AS FOLLOWS:

In a hermetically sealed sterile chamber, pre-treated, the patient's blood is delivered in dosed portions to AIDS (HIV) through a vein and a polymer tube. The patient's blood is divided into membrane filters into white blood cells by macrophages (monocytes) and T-lymphocytes.

After the patient's blood enters the hermetic reservoir and the magnetic field is created, a heated gas of ozone is supplied, which is distributed to atomic O and O 2 . This gas flushes T-lymphocytes and oxidizes the HIV-AIDS virus.

In the blood there are molecules consisting of iron, porphyrin and protein, in which iron binds to the oxygen molecule, without oxidizing at the same time. Oxidation of Fe (III) after the first stage is not carried out in them, oxygen is transported to various parts of the human organs of the patient with AIDS-HIV and acts under acidity conditions, with a lack of oxygen, one of its molecules transfers hemoglobin to the blood, another oxygen molecule stores myoglobin O 2 in muscle tissues until it is used in the cytochrome process. These chemical effects in the patient's body proceed after the return of blood to the patient from a vacuum sealed chamber, where the blood was additionally irradiated with a negative electric field of not more than 60 mV.

The iron atom, which is present in the blood, forms complexes with octahedral coordination. In cytochrome, the heme group is located in a depression on the surface of the protein molecules. From each wall of this slit hollow, one ligand is directed to the heme: a nitrogen atom belonging to the histidine protein group and a sulfur atom from the methionine group, so the iron atom is occupied from five sides by nitrogen atoms, and from the sixth side by the sulfur atom. The ligands in the complex around the iron and protein act on the oxidation-reduction chemistry of the iron atom and create a connection between the oxidation-reduction processes and the initial and subsequent links of the terminal oxidation chain.

AIDS-HIV viruses are developing to adapt to existing sources of food. The AIDS virus has a density in the sucrose gradient of 1.16 g / ml. In the center of the virion is located its core by an electronically dense nucleic acid, with a viral gene and internal proteins.

The internal gene is represented by RNA. The core is closed with a protein capsule, the outer part of the virion has a double linoid membrane that formed when passing through the cell surface. The sizes of virus parts reach 100 120 nm. From the surface of the membrane of the virus protrusions 9 nm in size and 15 nm in diameter protrude.

When exposed to ozone and a negative electric field up to 60 mV, these processes die, the AIDS-HIV virus loses its danger to the patient.

The genome AIDS-HIV has 9213 nucleotides and 7 genes, so it adapts to changes in the blood and body of the patient. The use of a magnetic field ensures the preservation of T-lymphocyte-peri-inductor.

In the process of vacuum mixing of the patient's blood with atomic oxygen and the presence of a constant electric field within 20-50 mV, the blood molecules exhibit the properties of polarization, excitability and conductivity, with each blood cell retaining its own electrical activity, which is summed. A negative electric field in the vacuum chamber provides recharging of the blood purified from the AIDS virus. On the surface of the blood cell there is a negative value, the inside charge is positive. Therefore, a constant electric field in the vacuum chamber is created negative. The membrane potential of the muscle fiber is related to the difference in the concentration of ions in the muscle fiber and in the extracellular environment.

The process of evacuation, mixing of blood in an electric field is provided simultaneously.

The results of applying this method are summarized in the table.

When these procedures were performed, positive results were obtained. Viral processes were destroyed, the virus did not pose a danger to the patient. The repeated procedure for washing with ozone is established by the attending physician in the detection of AIDS viruses after laboratory tests. After completion of the ozone washing of the patient's blood, AIDS is additionally administered to the patient with donor blood, as during evacuation a part of the blood has microcrack damage and mechanical surface changes. Donor blood provides restoration of the patient's immune system.

This method increases the therapeutic effect and shortens the treatment time.

CLAIM

1. A method for purifying blood from an AIDS virus, including placing it in a sealed sterile chamber, creating a vacuum therein, and then maintaining it under vacuum, characterized in that, in order to increase the therapeutic effect, the blood saturation in the chamber is carried out in a constant electric field with a negative charge , While some oxygen molecules are transported to various parts of the patient's organs without oxidation.

2. A method according to claim 1, characterized in that the blood purification process, mixing, the action of the negative electric field is carried out simultaneously.

3. The method of claim 1. 1 and 2, characterized in that after cleaning the patient's blood in a sealed vacuum chamber, the patient is additionally injected with a portion of the donor blood.

print version
Date of publication 06.01.2007gg